Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations for non-diabetes specialists on the use of sodium glucose co-transporter 2 inhibitors in people with type 2 diabetes (January 2021)

Sodium glucose co-transporter 2 (SGLT2) inhibitors are now an established class of medications for the treatment of type 2 diabetes (T2D), no longer reserved for use by specialists in diabetes. They are being used increasingly for their cardiac and renal benefits by primary care, cardiology and rena...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Med (Lond)
Main Authors: Dashora, Umesh, Gregory, Robert, Winocour, Peter, Dhatariya, Ketan, Rowles, Susannah, Macklin, Andrew, Rayman, Gerry, Nagi, Dinesh, Whitehead, Katie, Beba, Hannah, De, Parijat, Patel, Dipesh C
Formato: Artigo
Idioma:Inglês
Publicado: Royal College of Physicians 2021
Assuntos:
Concise Guidance
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8140708/
https://ncbi.nlm.nih.gov/pubmed/34001571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7861/clinmed.2021-0045
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares